Registry of the Spanish Network for Systemic Sclerosis: Clinical Pattern According to Cutaneous Subsets and Immunological Status

Seminars in Arthritis and Rheumatism

Volumn 41, Issue 6, 2012, Pages 789-800

  Simeón Aznar, Carmen Pilar ^a   Fonollosa Plá, Vicent ^a   Tolosa Vilella, Carles ^b   Espinosa Garriga, Gerard ^c   Ramos Casals, Manel ^c   Campillo Grau, Mercedes ^d   García Hernández, Francisco José ^e   Castillo Palma, María Jesús ^e   Sánchez Román, Julio ^e   Callejas Rubio, José Luis ^f   Ortego Centeno, Norberto ^f   Egurbide Arberas, Maria Victoria ^g   Trapiellla Martínez, Luis ^h   Gallego Villalobos, María ^h   Sáez Comet, Luis ⁱ   Velilla Marco, José ⁱ   Camps García, María Teresa ^j   de Ramón Garrido, Enrique ^j   Esteban Marcos, Eva María ^k   Pallarés Ferreres, Lucio ^k   Hidalgo Tenorio, Carmen ^l   Sabio Sánchez, José Mario ^l   Gómez de la Torre, Ricardo ^m   Salvador Cervello, Gonzalo ⁿ   Rios Blanco, Juan José ^o   Gil Aguado, Antonio ^o   Vilardell Tarrés, Miquel ^a   more..

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL DE SABADELL   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^g HOSPITAL DE CRUCES   (Spain)

^h HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

ⁱ HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^j HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^k HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^l HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^m HOSPITAL SAN AGUSTÍN   (Spain)

ⁿ HOSPITAL UNIVERSITARIO LA FE   (Spain)

^o HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

more..

Author keywords

"prescleroderma" or early scleroderma; Anticentromere antibodies; Antitopoisomerase I antibodies; Diffuse cutaneous SSc; Limited cutaneous SSc; SSc sine scleroderma; Systemic sclerosis

Indexed keywords

AUTOANTIBODY; CENTROMERE ANTIBODY; DNA TOPOISOMERASE ANTIBODY; UNCLASSIFIED DRUG;

ACROOSTEOLYSIS; ADULT; ARTHRALGIA; ARTICLE; CALCINOSIS; CLINICAL FEATURE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIFFUSE SCLERODERMA; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE REGISTRY; ECHOCARDIOGRAPHY; ESOPHAGUS DISEASE; ETHNIC GROUP; FEMALE; FINGER ULCER; HUMAN; INCIDENCE; INTERSTITIAL LUNG DISEASE; KIDNEY DISEASE; LIMITED SCLERODERMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MUSCULOSKELETAL DISEASE; ONSET AGE; PREDICTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; SEX RATIO; SJOEGREN SYNDROME; SPANISH; SYSTEMIC SCLEROSIS; SYSTOLIC BLOOD PRESSURE; TELANGIECTASIA;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INCIDENCE; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PULMONARY FIBROSIS; REGISTRIES; SCLERODERMA, SYSTEMIC; SPAIN;

EID: 84861224559     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2011.10.004     Document Type: Article

References (48)

1. Medsger T.A., Masi A.T. Epidemiology of systemic sclerosis (scleroderma). Ann Intern Med 1971, 74:714-721.
2. Maricq H.R., Weinrich M.C., Keil J.E., Smith E.A., Harper F.E., Nussbaum A.I., et al. Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 1989, 32:998-1006.
3. Mayes M. Scleroderma epidemiology. Rheum Dis Clin N Am 2003, 29:239-254.
4. Mayes M.D., Lacey J.V., Beebe-Dimmer J., Gillespie B.W., Cooper B., Laing T.J., et al. Prevalence, incidence, survival and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003, 48:2246-2255.
5. Michet C.J., McKenna C.H., Elveback L.R., Kaslow R.A., Kurland L.T. Epidemiology of systemic lupus erytematosus and other connective-tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1985, 60:105-113.
6. Steen V.D., Oddis C.V., Conte C.G., Janoski J., Casteline G.Z., Medsger T.A. Incidence of systemic sclerosis in Allegheny County, Pennsyvania: a twenty-year study of hospital-diagnosed cases, 1963-1982. Arthritis Rheum 1997, 40:441-445.
7. Arias-Núñez M.C., Llorca J., Vázquez-Rodríguez T.R., Gómez-Acebo I., Miranda-Filloy J.A., Martín J., et al. Systemic sclerosis in northwestern Spain. A 19-year epidemiologic study. Medicine 2008, 87:272-280.
8. Mayes M.D. Epidemiology of systemic sclerosis and related diseases. Curr Opin Rheumatol 1997, 9:557-561.
9. Mayes M., Laing T., Gillespi B. Prevalence, incidence and survival rates of systemic sclerosis in the detroit metropolitan area. Arthritis Rheum 1996, 39(Suppl):S150.
10. Silman A.J. Scleroderma-demographics and survival. J Rheumatol 1997, 48(Suppl):58-61.
11. Airo P., Tabaglio E., Frassi M., Scarsi M., Danieli E., Rossi M. Prevalence of systemic sclerosis in Valtrompia in Northern Italy. A collaborative study of rheumatologists and general practitioners. Clin Exp Rheumatol 2007, 25:878-880.
12. Alamanos Y., Tsifetaki N., Voulgari P.V., Siozos C., Tsamandouraki K., Alexiou G.A., et al. Epidemiology of systemic sclerosis in northwest Greece 1981 to 2002. Semin Arthrtitis Rheum 2005, 34:714-720.
13. Le Guern V., Mahr A., Mouthon L., Jeanneret D., Carzon M., Guillevin L. Prevalence of systemic sclerosis in a French multi-ethnic county. Rheumatology 2004, 43:1129-1137.
14. Matucci-Cerinic M., Steen V., Nash P., Hachulla E. The complexity of managing systemic sclerosis: screening and diagnosis. Rheumatology 2009, 48:iii8-iii13.
15. Matucci-Cerinic M., Allanore Y., Czirják L., Tyndall A., Müller-Ladner U., Denton C., et al. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. Ann Rheum Dis 2009, 68:1377-1380.
16. Preliminary Criteria for the Classification of Systemic Sclerosis (Scleroderma). Arthritis Rheum 1980, 23(3):581-586. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.
17. LeRoy B.C., Medsger T.A. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001, 28:1573-1576.
18. Poormoghim H., Lucas M., Fertig N., Medsger T.A. Systemic sclerosis sine scleroderma: demographic, clinical and serologic features and survival in forty-eight patients. Arthritis Rheum 2000, 43:444-451.
19. Rodnan G.P., Fennel R.H. Progressive systemic sclerosis sine scleroderma. J Am Med Assoc 1962, 180:665-670.
20. Steen V.D. The many faces of scleroderma. Rheum Dis Clin North Am 2008, 34:1-15.
21. Simeón C.P., Armadans L., Fonollosa V., Vilardell M., Candell J., Tolosa C., et al. Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology (Oxford) 2003, 42(1):71-75.
22. Simeón C.P., Armadans Ll, Fonollosa V., Solans R., Selva A., Villar M., et al. Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis. Ann Rheum Dis 1997, 56:723-728.
23. Bryan C., Howard Y., Brennan P., Black C., Silman A. Survival following the onset of scleroderma: results froma a retrospective inception cohort study of the UK patient population. Br J Rheumatol 1996, 35:1122-1126.
24. Jacobsen S., Halberg P., Ullman S. Mortality and causes of death of 344 Danish patients with systemic sclerosis. Br J Rheumatol 1998, 37:750-755.
25. Hesselstrans R., Scheja A., Akeson Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998, 57:682-686.
26. Walker U.A., Tyndall A., Czirják L., Denton C., Farge-Bancel D., Kowal-Bielecka O. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR scleroderma trials and research group database. Ann Rheum Dis 2007, 66:754-763. EUSTAR Coauthors.
27. Joven B.E., Almodovar R., Carmona L., Carreira P.E. Survival, causes of death and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single University Hospital. Semin Arthritis Rheum 2010, 34(4):285-293.
28. Castell J., Fraile M., Candell J., Simeón C.P., Fonollosa V., Alonso F., et al. Myocardial perfusion imaging in scleroderma and Raynaud's phenomenon. Eur J Nucl Med 1992, 19:660.
29. Traub Y.M., Shapiro A.P., Rodnan G.P., Medsger T.A., McDonald R., Steen V.D., et al. Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Medicine (Baltimore) 1985, 62:335-352.
30. Maricq H.R., Spencer-Geen G., Le Roy E.C. Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis). Raynaud's syndrome and dermatomyositis. Am J Med 1976, 61:862-870.
31. Walker J.G., Pope J., Baron M., Leclercq S., Hudson M., Taillefer S., et al. The development of systemic sclerosis classification criteria. Clin Rheumatol 2007, 26:1401-1409.
32. Wigley F.M. When is scleroderma really scleroderma?. J Rheumatol 2001, 28:1471-1473.
33. LeRoy E.C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T.A., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15:202-205.
34. Silman A., Jannini S., Symmons D., Bacon P. An epidemiological study of scleroderma in the West Midlands. Br J Rheumatol 1988, 27:286-290.
35. Tamaki T., Mori S., Takehara K. Epidemiological study of patients with systemic sclerosis in Tokyo. Arch Dermatol Res 1991, 283:366-371.
36. Hunzelmann N., Genth E., Krieg T., Lehmacher W., Merchers I., Meurer M., et al. The registry of the German network for systemic scleroderma; frequency of disease subsets and patterns of organ involvement. Rheumatology 2008, 47(8):1185-1192.
37. Lonzetti L.S., Joyal F., Raynauld J.P., Roussin A., Goulet J.R., Rich E. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001, 44:735-736.
38. Fisher A., Meehan R.T., Feghali-Bostwick C.A., West S.G., Brown K.K. Unique characteristics of systemic sclerosis sine slceroderma-associated interstitial lung disease. Chest 2006, 130(4):976-981.
39. Abrams H.L., Carnes W.H., Eaton J. Alimentary tract in disseminated scleroderma with emphasis on small bowel. Arch Intern Med 1954, 94:61-81.
40. Rodnan G.P., Fennel R.H. Progressive systemic sclerosis sine scleroderma. JAMA 1962, 180:665-670.
41. Miller R.D., Fowler S., Helmnholz F. Scleroderma of the lung. Mayo Clin Proc 1959, 34:66-75.
42. Horswell R.R., Hargrove M.D., Peete W.P. Scleroderma presenting as the malabsorption syndrome. Gastroenterology 1960, 40:580-582.
43. Crown S. Visceral scleroderma without skin involvement. BJM 1961, 2:1541-1543.
44. Giordano M., Valentini G., Vatti M., Gallo M., Ticci G. Systemic sclerosis sine scleroderma and correlated diagnostic problems. Connect Tissue Dis 1982, 1:115-136.
45. De Villiers W.J.S., Jardann H.F., Bates W. Systemic sclerosis sine scleroderma presenting with vitiligo-like depigmentation and interstitial pulmonary fibrosis. Clin Exp Dermatol 1992, 17:127-131.
46. Ferri C., Bernnini L., Germinagnal G. Lung involvement in systemic sclerosis sine scleroderma treated by plasma exchange. Int J Artif Organs 1992, 15:426-431.
47. Molina J.F., Anaya J.M., Cabrera G.E., Hoffman E., Espinoza L.R. Systemic sclerosis sine scleroderma: an unusual presentation in scleroderma renal crisis. J Rheumatol 1995, 22:557-560.
48. Sato S., Hanaguchi Y., Hasegawa M., Takehara K. Clinical significance of antitopoisomerase I antibody levels determined by ELISA in systemic sclerosis. Rheumatology 2001, 40:1135-1140.